Chemistry Reference
In-Depth Information
17. Potier P. The synthesis of navelbine: prototype of a new series of vinblastine deriva-
tives. Sem. Oncol. 1989;16:2-4.
18. Jenks S, Smigel K. Updates: cancer drug approved; new leukemia treatment. J. Nat.
Cancer Inst. 1995;87:167-170.
19. Vlahov IR, Santhapuram HKR, Kleindl PJ, Howard SJ, Stanford KM, Leamon CP.
Design and regioselective synthesis of a new generation of targeted chemotherapeu-
tics. Part I: ED145, a folic acid conjugate of desacetylvinblastine monohydrazide.
Bioorg. Med. Chem. Lett. 2006;16:5093-5096.
20. Okouneva T, Hill BT, Wilson L, Jordan MA. The effects of vinflunine, vinorelbine,
and vinblastine on centromere dynamics. Mol. Cancer Ther. 2003;2:427-436.
21. Kruczynski A, Barret JM, Erievant C, Colpaert F, Fahy J, Hill BT. Antimitotic
and tubulin-interacting properties of vinflunine, a novel fluorinated Vinca alkaloid.
Biochem. Pharmacol. 1998;55:635-648.
22. Wani MC, Tayler HI, Wall ME, Coggon P, McPhail AT. Plant antitumor agents. VI.
The isolation and structure of taxol, a novel antileukemia and antitumor agent from
Taxus brevifolia. J. Am. Chem. Soc. 1971;93:2325-2327.
23. Itokawa H, Lee KH, eds. Taxus: Genus Taxus. 2003. Taylor & Francis, London.
24. Shigemori H, Kobayashi J. Biological activity and chemistry of taxoids from the
Japanese yew, Taxus cuspidate. J. Nat. Prod. 2004;67:245-256.
25. Cragg GM, Suffness M. Metabolism of plant-derived anticancer agents. Pharmcol.
Ther. 1988;37:425-461.
26. Kingston DG. The chemistry of taxol. Pharmcol. Ther. 1991;52:1-34.
27. Geney R, Chen J, Ojima I. Recent advances in the new generation taxane anticancer
agents. Med. Chem. 2005;1:125-139.
28. Appendino G, Bettoni P, Noncovich A, Sterner O, Fontana G, Bombardelli E, Pera
P, Bernack RJ. Structure-activity relationship of ring C-secotaxoids. 1. Acylative
modifications. J. Nat. Prod. 2004;67:184-188.
29. Liu C, Strobl JS, Bane S, Schilling JK, McCracken M, Chatterjee SK, Rahim-
Bata R, Kingston DGI. Design, synthesis, and bioactivities of steroid-linked taxol
analogues as potential targeted drugs for prostate and breast cancer. J. Nat. Prod.
2004;67:152-159.
30. Kuznetsova L, Chen J, Sun L, Wu X, Pepe A, Veith JM, Pera P, Bernacki RJ, Ojima
I. Syntheses and evaluation of novel fatty acid-second generation taxoid conjugates
as promising anticancer agents. Bioorg. Med. Chem. Lett. 2006;16:974-977.
31. Raez LE, Lilenbaum R. New developments in chemotherapy for advanced non-small
cell lung cancer. Curr. Opin. Oncol. 2006;18:156-161.
32. Singer JW, Shaffer S, Baker B, Gbernareggi A, Stromatt S, Nienstedt D, Besman
M. Paclitaxel poliglumex (XYOTAX; CT-2103): an intracellularly targeted taxane.
Anticancer Drugs 2005;16:243-254.
33. Shi Q, Wang HK, Bastow KF, Tachibana Y, Chen K, Lee FY, Lee KH. Antitumor
agents 210. Synthesis and evaluation of taxoid-epipodophyllotoxin conjugates as
novel cytotoxic agents. Bioorg. Med. Chem. 2001;9:2999-3004.
34. Ohtsu H, Nakanishi Y, Bastow KF, Lee FY, Lee KH. Antitumor agents 216. Synthe-
sis and evaluation of paclitaxel-camptothecin conjugates as novel cytotoxic agents.
Bioorg. Med. Chem. 2003;11:1851-1857.
